These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37897151)

  • 1. Longitudinal EpiTrack assessment of executive functions following vagus nerve stimulation therapy in patients with drug-resistant epilepsy.
    Lähde N; Basnyat P; Raitanen J; Lehtimäki K; Rosti-Otajärvi E; Peltola J
    Epilepsia Open; 2024 Feb; 9(1):150-163. PubMed ID: 37897151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex executive functions assessed by the trail making test (TMT) part B improve more than those assessed by the TMT part A or digit span backward task during vagus nerve stimulation in patients with drug-resistant epilepsy.
    Lähde N; Basnyat P; Raitanen J; Kämppi L; Lehtimäki K; Rosti-Otajärvi E; Peltola J
    Front Psychiatry; 2024; 15():1349201. PubMed ID: 38419904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpiTrack is a feasible tool for assessing attention and executive functions in patients with refractory epilepsy.
    Lähde N; Basnyat P; Lehtinen H; Rainesalo S; Rosti-Otajärvi E; Peltola J
    Epilepsy Behav; 2021 Feb; 115():107691. PubMed ID: 33360402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
    Evans K; Stamas N; Li Q; Vincent T; Halchenko Y; Zhang L; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    Clin Ther; 2023 Feb; 45(2):136-150. PubMed ID: 36746736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Polytherapy on Memory Functioning in Patients With Drug-Resistant Epilepsy: The Role of Attention and Executive Functions.
    Lozano-García A; Catalán-Aguilar J; Tormos-Pons P; Hampel KG; Villanueva V; Cano-López I; González-Bono E
    Arch Clin Neuropsychol; 2024 May; 39(4):423-442. PubMed ID: 37987193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital costs associated with vagus nerve stimulation and medical treatment in pediatric patients with refractory epilepsy.
    Zhang L; Hall M; Lam SK
    Epilepsia; 2022 May; 63(5):1141-1151. PubMed ID: 35188675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex.
    Tong X; Wang X; Qin L; Zhou J; Guan Y; Teng P; Wang J; Yang Y; Li T; Luan G
    Epilepsy Behav; 2022 Jan; 126():108431. PubMed ID: 34883463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
    Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology.
    Xie H; Ma J; Ji T; Liu Q; Cai L; Wu Y
    Epilepsy Behav; 2023 Mar; 140():109107. PubMed ID: 36758359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable combinations of antiseizure medication with vagus nerve stimulation to improve health-related quality of life in patients with epilepsy.
    Sauer V; Glaser M; Ellwardt E; Saryyeva A; Krauss JK; Ringel F; Groppa S; Winter Y
    Epilepsy Behav; 2024 Jan; 150():109562. PubMed ID: 38071825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vagus nerve stimulation on emergency department utilization in children with drug-resistant epilepsy: a retrospective cohort study.
    Muthiah N; Reecher HM; Abel TJ
    J Neurosurg Pediatr; 2024 Jun; ():1-8. PubMed ID: 38905712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry.
    Kawai K; Tanaka T; Baba H; Bunker M; Ikeda A; Inoue Y; Kameyama S; Kaneko S; Kato A; Nozawa T; Maruoka E; Osawa M; Otsuki T; Tsuji S; Watanabe E; Yamamoto T
    Epileptic Disord; 2017 Sep; 19(3):327-338. PubMed ID: 28832004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long-term survival with continued medical therapy, vagus nerve stimulation, and cranial epilepsy surgery in paediatric patients with drug-resistant epilepsy in the USA: an observational cohort study.
    Zhang L; Hall M; Lam SK
    Lancet Child Adolesc Health; 2023 Jul; 7(7):455-462. PubMed ID: 37276875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of traditional and closed loop vagus nerve stimulation for treatment of pediatric drug-resistant epilepsy: A propensity-matched retrospective cohort study.
    Muthiah N; Akwayena E; Vodovotz L; Sharma N; Jeong JH; White GE; Abel TJ
    Seizure; 2022 Jan; 94():74-81. PubMed ID: 34872020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic vagus nerve stimulation reverses heart rhythm complexity in patients with drug-resistant epilepsy: An assessment with multiscale entropy analysis.
    Liu H; Yang Z; Meng F; Huang L; Qu W; Hao H; Zhang J; Li L
    Epilepsy Behav; 2018 Jun; 83():168-174. PubMed ID: 29709876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug-resistant epilepsy enrolled in a Russian VNS Registry.
    Feygina AA; Koshelyaevskaya YN; Dibué M; Voronkova KV; Klochkov MN; Koroleva NY; Ivanov SS; Bolshakova ES; Fatykhova EF
    Brain Behav; 2023 Jul; 13(7):e3076. PubMed ID: 37254623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior Nucleus of the Thalamus Deep Brain Stimulation with Concomitant Vagus Nerve Stimulation for Drug-Resistant Epilepsy.
    Parisi V; Lundstrom BN; Kerezoudis P; Alcala Zermeno JL; Worrell GA; Van Gompel JJ
    Neurosurgery; 2021 Sep; 89(4):686-694. PubMed ID: 34333659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of vagus nerve stimulation and antiseizure medication.
    Winter Y; Sandner K; Glaser M; Ciolac D; Sauer V; Ziebart A; Karakoyun A; Chiosa V; Saryyeva A; Krauss J; Ringel F; Groppa S
    J Neurol; 2023 Oct; 270(10):4978-4984. PubMed ID: 37368131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.